On the heels of several studies that showed the benefit of alternative models in predicting safety in patients undergoing percutaneous coronary intervention (PCI), a subanalysis of 1-year results from the LEADERS trial reaffirms the value of the Syntax score in judging risk in a broad population receiving drug-eluting stents (DES). The findings appear in the July 20, 2010, issue of the Journal of the American College of Cardiology.

In the multicenter European LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial, researchers led by Patrick W. Serruys, MD, PhD, of Erasmus Medical Center (Rotterdam, The Netherlands), compared the safety ....

You must be a member to access this content. To continue reading, please enter your username and password above.

If you have not yet registered, we would like to take this opportunity to welcome you to TCTMD - The Source for Interventional Cardiovascular News & Education.

If you are already a member, please re-enter your username and password above, and then click LOGIN.

For questions regarding the registration process, please refer to our FAQ documentation or contact customer service.